The tumor microenvironment regulates tumor initiation, progression, and metastasis.
We summarize the use of biomaterials in tumor modeling in vitro.
Engineered tumor models are becoming increasingly complex and heterotypic.
Insights into drug resistance may inform the development of novel therapeutic targets.